2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

The "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy" provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy. A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the "2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy" have been updated with new evidence to guide clinicians.

Writing Committee Members ，Ommen SR ，Ho CY ，Asif IM ，Balaji S ，Burke MA ，Day SM ，Dearani JA ，Epps KC ，Evanovich L ，Ferrari VA ，Joglar JA ，Khan SS ，Kim JJ ，Kittleson MM ，Krittanawong C ，Martinez MW ，Mital S ，Naidu SS ，Saberi S ，Semsarian C ，Times S ，Waldman CB ... -  《-》

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

Ommen SR ，Ho CY ，Asif IM ，Balaji S ，Burke MA ，Day SM ，Dearani JA ，Epps KC ，Evanovich L ，Ferrari VA ，Joglar JA ，Khan SS ，Kim JJ ，Kittleson MM ，Krittanawong C ，Martinez MW ，Mital S ，Naidu SS ，Saberi S ，Semsarian C ，Times S ，Waldman CB ，Peer Review Committee Members ... -  《-》

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Ommen SR ，Mital S ，Burke MA ，Day SM ，Deswal A ，Elliott P ，Evanovich LL ，Hung J ，Joglar JA ，Kantor P ，Kimmelstiel C ，Kittleson M ，Link MS ，Maron MS ，Martinez MW ，Miyake CY ，Schaff HV ，Semsarian C ，Sorajja P ... -  《-》

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use. A comprehensive literature search was conducted from January 1, 2010, to April 30, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. Many recommendations from the earlier hypertrophic cardiomyopathy guidelines have been updated with new evidence or a better understanding of earlier evidence. This summary operationalizes the recommendations from the full guideline and presents a combination of diagnostic work-up, genetic and family screening, risk stratification approaches, lifestyle modifications, surgical and catheter interventions, and medications that constitute components of guideline directed medical therapy. For both guideline-directed medical therapy and other recommended drug treatment regimens, the reader is advised to follow dosing, contraindications and drug-drug interactions based on product insert materials.

Ommen SR ，Mital S ，Burke MA ，Day SM ，Deswal A ，Elliott P ，Evanovich LL ，Hung J ，Joglar JA ，Kantor P ，Kimmelstiel C ，Kittleson M ，Link MS ，Maron MS ，Martinez MW ，Miyake CY ，Schaff HV ，Semsarian C ，Sorajja P ... -  《-》

2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Writing Committee Members ，Ommen SR ，Mital S ，Burke MA ，Day SM ，Deswal A ，Elliott P ，Evanovich LL ，Hung J ，Joglar JA ，Kantor P ，Kimmelstiel C ，Kittleson M ，Link MS ，Maron MS ，Martinez MW ，Miyake CY ，Schaff HV ，Semsarian C ，Sorajja P ，ACC/AHA Joint Committee Members ，O'Gara PT ，Beckman JA ，Levine GN ，Al-Khatib SM ，Armbruster A ，Birtcher KK ，Ciggaroa J ，Dixon DL ，de las Fuentes L ，Deswal A ，Fleisher LA ，Gentile F ，Goldberger ZD ，Gorenek B ，Haynes N ，Hernandez AF ，Hlatky MA ，Joglar JA ，Jones WS ，Marine JE ，Mark D ，Palaniappan L ，Piano MR ，Tamis-Holland J ，Wijeysundera DN ，Woo YJ ... -  《-》